Log In
English (USA)
English (UK)
English (Canada)
English (India)
Deutsch (Deutschland)
Deutsch (Österreich)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
Search
Announcement Date
Since
Until
Aurora Cannabis Brief: For Q1 2024, Expects Adjusted Gross Margins to be consistent with fiscal Q3 2023 and expects to maintain stated objective of a quarterly SG&A expense run rate below $30 million
June 14, 2023 at 07:17 am EDT